ChromaDex Corporation - שווי הפעילות העסקית CDXC

ChromaDex Corporation (CDXC) generates revenue through the sale of innovative longevity components via a subscription system, ensuring a reliable cash flow, while its success is driven by leading biogerontologists working in high-tech laboratories. The market trend for the asset on the GURU.Markets platform is . Meanwhile, patent protection allows the company to maintain wholesale pricing, although retail advertising expenses limit final margins.

Enterprise Value (EV) represents the total acquisition price of a business, combining market capitalization with net debt to determine the asset's real value. By analyzing the current EV level, an investor can see the valuation's sensitivity to liquidity, which is critical for ChromaDex Corporation (CDXC), as its production outsourcing model via contract manufacturing plants minimizes capital expenditures, directly impacting the debt load and the company's final valuation.